HCV

Drug holds promise of treating Hepatitis C, but cost prohibitive

A new drug has shown promise of treating the Hepatitis C virus (HCV) in India, something which had eluded health experts for long. But its widespread use may be inhibited because of its high cost - Rs.100,000 ($1,500) for the full course.

Know how Hepatitis C spreads

Chronic Hepatitis C is a serious disease that can result in long-term health problems. Approximately 60,000 people die every year from Hepatitis C related liver disease.

Experts raise alarm over growing Hepatitis C disease burden

It is estimated that prevalence of Hepatitis C infection in India is more than 6 times the prevalence of HIV infection. However no community level data are available.

Hepatitis C increases cancer risk

People infected with hepatitis C virus (HCV) may be at increased risk of various forms of cancers, including renal, prostate as well as liver cancer, warns a new research.

20 children get HIV, HCV due to transfusion of infected blood

Over 20 children suffering from Thalassaemia have tested positive for HIV and Hepatitis C allegedly after transfusion of infected blood at a govt hospital here, two years after a similar incident had prompted an inquiry by Govt.